GB9929783D0 - Toscana virus nucleoprotein - Google Patents

Toscana virus nucleoprotein

Info

Publication number
GB9929783D0
GB9929783D0 GBGB9929783.0A GB9929783A GB9929783D0 GB 9929783 D0 GB9929783 D0 GB 9929783D0 GB 9929783 A GB9929783 A GB 9929783A GB 9929783 D0 GB9929783 D0 GB 9929783D0
Authority
GB
United Kingdom
Prior art keywords
toscana virus
toscana
virus nucleoprotein
virus
antigen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB9929783.0A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Universita degli Studi di Siena
Original Assignee
Universita degli Studi di Siena
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Universita degli Studi di Siena filed Critical Universita degli Studi di Siena
Priority to GBGB9929783.0A priority Critical patent/GB9929783D0/en
Publication of GB9929783D0 publication Critical patent/GB9929783D0/en
Priority to ES00987600T priority patent/ES2293934T3/en
Priority to EP00987600A priority patent/EP1237571B1/en
Priority to AU23901/01A priority patent/AU2390101A/en
Priority to PCT/IB2000/002031 priority patent/WO2001044288A2/en
Priority to DE60036563T priority patent/DE60036563T2/en
Priority to AT00987600T priority patent/ATE374040T1/en
Priority to PT00987600T priority patent/PT1237571E/en
Priority to DK00987600T priority patent/DK1237571T3/en
Priority to CY20071101586T priority patent/CY1107607T1/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/12011—Bunyaviridae
    • C12N2760/12022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/12011—Bunyaviridae
    • C12N2760/12034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Silicates, Zeolites, And Molecular Sieves (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

Surprinsingly, it has been discovered that the core protein antigen of Toscana virus can induce a protective humoral response. The invention relates to compositions comprising Toscana virus nucleoprotein. These may be used in the treatment or prophylaxis of Toscana virus infection. Also provided is the use of an internal virus antigen in the manufacture of a medicament for eliciting a neutralising humoral anti-viral immune response.
GBGB9929783.0A 1999-12-16 1999-12-16 Toscana virus nucleoprotein Ceased GB9929783D0 (en)

Priority Applications (10)

Application Number Priority Date Filing Date Title
GBGB9929783.0A GB9929783D0 (en) 1999-12-16 1999-12-16 Toscana virus nucleoprotein
DK00987600T DK1237571T3 (en) 1999-12-16 2000-12-18 Toscana virus nukleinprotein
PCT/IB2000/002031 WO2001044288A2 (en) 1999-12-16 2000-12-18 Toscana virus nucleoprotein
EP00987600A EP1237571B1 (en) 1999-12-16 2000-12-18 Toscana virus nucleoprotein
AU23901/01A AU2390101A (en) 1999-12-16 2000-12-18 Toscana virus nucleoprotein
ES00987600T ES2293934T3 (en) 1999-12-16 2000-12-18 TUSCAN VIRUS NUCLEOPROTEIN.
DE60036563T DE60036563T2 (en) 1999-12-16 2000-12-18 NUCLEOPROTEIN OF TUSCANAVIRUS
AT00987600T ATE374040T1 (en) 1999-12-16 2000-12-18 NUCLEOPROTEIN OF THE TOSCANA VIRUS
PT00987600T PT1237571E (en) 1999-12-16 2000-12-18 Toscana virus nucleoprotein
CY20071101586T CY1107607T1 (en) 1999-12-16 2007-12-14 TOSCANA NUCLEAR PROTEIN

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9929783.0A GB9929783D0 (en) 1999-12-16 1999-12-16 Toscana virus nucleoprotein

Publications (1)

Publication Number Publication Date
GB9929783D0 true GB9929783D0 (en) 2000-02-09

Family

ID=10866464

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB9929783.0A Ceased GB9929783D0 (en) 1999-12-16 1999-12-16 Toscana virus nucleoprotein

Country Status (10)

Country Link
EP (1) EP1237571B1 (en)
AT (1) ATE374040T1 (en)
AU (1) AU2390101A (en)
CY (1) CY1107607T1 (en)
DE (1) DE60036563T2 (en)
DK (1) DK1237571T3 (en)
ES (1) ES2293934T3 (en)
GB (1) GB9929783D0 (en)
PT (1) PT1237571E (en)
WO (1) WO2001044288A2 (en)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5298423A (en) * 1987-11-25 1994-03-29 The United States Of America As Represented By The Secretary Of The Army Nucleotide sequences encoding the expression of a Hantaan virus nucleocapsid protein and G1 and G2 glycoproteins
ITMI980889A1 (en) * 1998-04-24 1999-10-24 Diesse Diagnostica RECOMBINANT NUCLEOPROTEIN OF THE TUSCAN VIRUS

Also Published As

Publication number Publication date
ATE374040T1 (en) 2007-10-15
EP1237571A2 (en) 2002-09-11
DE60036563D1 (en) 2007-11-08
ES2293934T3 (en) 2008-04-01
EP1237571B1 (en) 2007-09-26
DK1237571T3 (en) 2008-01-02
PT1237571E (en) 2007-12-31
CY1107607T1 (en) 2013-03-13
AU2390101A (en) 2001-06-25
WO2001044288A3 (en) 2002-01-24
DE60036563T2 (en) 2008-07-17
WO2001044288A2 (en) 2001-06-21

Similar Documents

Publication Publication Date Title
MX2008013993A (en) Cd40 agonist antibody/type1 interferon synergistic adjuvant combination, conjugates containing and use thereof as a therapeutic to enhance cellular immunity.
HUP0401606A2 (en) West nile vaccine
WO2006068663A3 (en) Vaccine compositions for treating coronavirus infection
ATE320493T1 (en) MODIFICATION OF HEPATITIS B CORE ANTIGEN
WO2009072767A3 (en) A powerful vaccine composition comprising a lipopeptide and poly i:c as an adjuvant
WO2005116270A3 (en) Influenza virus vaccine composition and method of use
MXPA02012443A (en) 3 -PRODRUGS OF 2 -DEOXY-bgr;-L-NUCLEOSIDES.
DE60031874D1 (en) IMMUNOLOGICALLY RELEVANT ANTIGENS FROM HERPES SIMPLEXVIRUS
WO2009060281A3 (en) Immune stimulatory oligoribonucleotide analogs containing modified oligophosphate moieties
EP1471936A4 (en) Hiv vaccine and method of use
WO2005028496A3 (en) Vaccine for treatment and prevention of herpes simplex virus infection
WO2003011893A3 (en) Immunologically significant herpes simplex virus antigens and methods for using same
HK1047892A1 (en) Hcv vaccine compositions
UY26882A1 (en) NEW TREATMENT
PL1949913T3 (en) Immunostimulatory combination for the prophylactics and treatment of hepatitis c
MX2007002659A (en) Vaccine composition against hepatitis c virus.
EP1305042A4 (en) Compositions and methods for treatment of mucosal infections
WO2002034287A3 (en) Therapeutic vaccine formulations containing chitosan
WO2003053338A3 (en) Novel chimeric rev, tat, and nef antigens
GB9929783D0 (en) Toscana virus nucleoprotein
ATE378351T1 (en) THERAPEUTIC VACCINE COMPOSITION FOR PREVENTING AND TREATING DISEASES IN MAMMALS
WO2002041921A3 (en) Compositions for protection against bovine viral diseases
AR027738A1 (en) COMPOSITION COADYUVANTE, COMPOSITIONS OF VACCINES THAT INCLUDE SUCH COMPOSITION COADYUVANTE; PROCEDURE FOR INDUCTION OF IMMUNE IMMUNORESPUESTAS AMMAMIFEROS AND PROCEDURE OF TREATMENT WHERE SUCH VACCINES APPLY
WO2003020306A1 (en) Desensitizers
WO2002096940A3 (en) Attenuated very virulent infectious bursal disease virus

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)